Compare Costco Wholesale Corporation (COST) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Costco Wholesale Corporation vs Nuwellis Inc — how do they compare? Costco Wholesale Corporation trades at $922.75 (market cap $408.78B), while Nuwellis Inc trades at $3.25 (market cap $1.17M). The key difference: Costco Wholesale Corporation is far larger — about 349384.6× Nuwellis Inc's market cap, and Costco Wholesale Corporation pays a 0.64% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| COST | NUWE | |
|---|---|---|
Market Cap | $408.78B | $1.17M |
Sector | Consumer Staples | Technology |
52-Week High | $1.09K | $558.26 |
52-Week Low | $849.63 | $2.80 |
Enterprise Value | $396.92B | -$636.97K |
Dividend Yield | 0.64% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Costco (COST) trades at $921.73, down 0.51% on the day, with a bearish technical signal but strong fundamental growth. Revenue reached $275.24B in 2025 with net income of $8.10B, and March 2026 sales grew 11.3% year-over-year. The stock carries premium valuations (P/E 46.37, P/S 1.4) while maintaining steady margin expansion. Analyst consensus remains strongly bullish with a $1,120 price target, though recent earnings miss in Q1 2026 highlights execution risks amid high expectations.
Outlook: Costco's membership fee increase and warehouse expansion support long-term growth, but elevated valuation requires flawless execution. Risks include competitive pressures and macroeconomic sensitivity. Institutional accumulation continues, with 65% analyst buy ratings signaling confidence in the company's resilient business model and cash flow generation.
NUWE trades at $2.80, down 7.89% in the last session, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025 despite $8.27M revenue, reflecting negative profit margins and cash flow challenges. Recent news highlights expansion in pediatric care and a $6M public offering closed in June 2026, alongside a CEO transition to Mike McCormick effective June 30, 2026.
Outlook remains high-risk due to persistent losses and cash burn, though analyst consensus is split evenly between Buy and Hold. Key risks include execution in revenue growth and reliance on financing. Upside depends on successful commercialization of Aquadex therapy and FDA label expansion for pediatric patients.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Costco Wholesale Corporation
The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet
Read more on COST →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
